BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9

• Press Releases

  Moonlight Therapeutics Initiates Phase I Clinical Trial (SURVEYOR) of MOON101 for Peanut Allergy

  June 3, 2026

   · 

  4 min read
• Press Releases

  FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients

  June 3, 2026

   · 

  4 min read
• Press Releases

  Novellia Secures $18M Series A to Scale Patient-Powered Data Platform, Solving Pharma’s $50B Problem

  June 3, 2026

   · 

  4 min read
• Press Releases

  Nephrodite’s Holly™ Implantable Continuous Dialysis System Awarded Selection into FDA’s TAP to Accelerate Development and Patient Access

  June 3, 2026

   · 

  3 min read
• Press Releases

  Sanofi Chooses Snowflake to Accelerate its AI-Powered Drug Development

  June 3, 2026

   · 

  4 min read
• Press Releases

  AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share

  June 3, 2026

   · 

  5 min read
• Press Releases

  Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

  June 3, 2026

   · 

  5 min read
• Press Releases

  Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

  June 3, 2026

   · 

  2 min read
• Press Releases

  Rise Therapeutics Completes Enrollment in Four-Week Dose Expansion Cohort for the R-2487 Rheumatoid Arthritis Clinical Trial

  June 3, 2026

   · 

  4 min read
• Press Releases

  CAVHANZA™ (nilotinib) Orally Disintegrating Tablets: A New, FDA-approved Treatment Offering PPI and H2RA Flexibility for Ph+ CML Patients1

  June 3, 2026

   · 

  7 min read